Outlook Therapeutics closes $5M private placement to Syntone Ventures

Outlook Therapeutics, Inc.

Issued 714,286 shares and warrants to purchase 1,071,429 shares at $7.00 per share+ warrant.
Warrant exercise price is $7.70 per share, expiring April 15, 2029.
Sale relied on Section 4(a)(2) and Rule 506 exemptions without registration.
Syntone Ventures LLC is the sole investor in the private placement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.